Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination (Q33187560)

23 July 2017

title

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination (English)

1 reference

23 July 2017

0 references

restrictive lung disease

1 reference

David M Mannino

0 references

Earl S Ford

1 reference

23 July 2017

Stephen C Redd

series ordinal

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

American Journal of Medicine

23 July 2017

published in

1 reference

23 July 2017

volume

114

1 reference

23 July 2017

1 reference

23 July 2017

page(s)

758-762

1 reference

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Death certificate reporting of confirmed airways obstructive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

C-reactive protein in healthy and in sick populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Spirometric reference values from a sample of the general U.S. population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

inferred from DOI database lookup

7 January 2021

based on heuristic

The course and prognosis of different forms of chronic airways obstruction in a sample from the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Twenty-year trends in mortality from chronic obstructive pulmonary disease: the Honolulu Heart Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Systemic effects in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Remodeling in asthma and chronic obstructive lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Pulmonary sarcoidosis: patterns of cytokine release in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Human lymphocytes synthesize C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Response of C-reactive protein and serum amyloid A to influenza A infection in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Coronary heart disease and iron status: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

Effects of smoking and abstention from smoking on fibrinogen synthesis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900185-2

10.1016/S0002-9343(03)00185-2

7 January 2021

Identifiers

DOI

1 reference

23 July 2017

1 reference